...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Trading
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Hmmm, that's interesting. See 2A.  CTO should be lifted once that's corrected I would expect.

https://cto-iov.csa-acvm.ca/ArticleFile.asp?Instance=101&ID=E4A6BCAF076F4977A3E39662B5B6CC47

3 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply